wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q36059239-7ACE96F9-D2AB-4760-B632-BE9CC9F4F03D
Q36059239-7ACE96F9-D2AB-4760-B632-BE9CC9F4F03D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36059239-7ACE96F9-D2AB-4760-B632-BE9CC9F4F03D
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
P2860
Q36059239-7ACE96F9-D2AB-4760-B632-BE9CC9F4F03D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36059239-7ACE96F9-D2AB-4760-B632-BE9CC9F4F03D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
114208b70a27fbdf8f17b15cc04d6df830c60f1e
P2860
A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.